NEW YORK--(BUSINESS WIRE)--DDC Enterprise Limited (“DDC” or the “Company”) today announced the acquisition of 100 Bitcoin (BTC) as part of its ongoing corporate treasury strategy. This marks the company's second Bitcoin purchase within a week, bringing DDC's total holdings to 588 BTC. The transaction reflects DDC's continued execution of its disciplined Bitcoin treasury strategy and long-term goal of building one of the world's leading public Bitcoin treasuries. Purchase Highlights: Treasury Gr.

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer 2025 Baird Global Healthcare Conference Tuesday, September 9, 2025 2:35 p.m. ET – Steve Willoughby, senior vice president, investor relations & ESG Attendees will receive an update on the Company and its strategic p.

WALLINGFORD, Conn.--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) today announced a definitive agreement to acquire Trexon for approximately $1 billion in cash, subject to customary post-closing adjustments. Trexon is a leading provider of high-reliability interconnect and cable assemblies primarily for the defense market. Headquartered in Boston, Massachusetts and with facilities in the U.S. and the U.K., Trexon is expected to have 2025 sales and EBITDA margins of approximately $290 millio.

Singapore , Aug. 18, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (Nasdaq: YYGH) (“YY Group,” “YYGH” or the “Company”), a leading global provider of on-demand workforce solutions and integrated facilities management (“IFM”) services, today announced that its dual-engine artificial intelligence (“AI”) algorithm has been designated as the Company's core strategic asset for the next phase of growth. This initiative is designed to accelerate the pace of internal and external technology upgrades while broadening future revenue streams.

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC) in or traceable to the Company's October 2024 initial public offering (the “IPO”). Should You Join This Class Action Lawsuit?

Superior drilling results continue to exceed the Company's expectations and are expanding Tanbreez at vast scale and build upon very successful past Tanbreez drilling results. Consistent uniformity across the deposits intersecting ultra high-grade rare earth element mineralisation intersected in all four reported holes, with total rare earth oxide (TREO) grades between 0.48% and 0.55%.

HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) reports net assets as of June 30, 2025, of $34.1 million. Net asset value per share decreased to $2.51 as of June 30, 2025, from $2.52 as of March 31, 2025.

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) between May 7 , 202 5 and July 28 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

Retired all principal and accrued interest owed its two senior secured lenders, Resorts World Inc. Pte. Ltd., or RWI, and C.V.

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) between April 29, 2025 and June 22, 2025, inclusive. Should You Join This Class Action Lawsuit?

New York, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update note on MAIA Biotechnology, Inc. (NYSE: MAIA) following quarterly results. The update note includes detailed information on the MAIA Biotechnology's business, recent updates, management commentary, financial results, valuation, and risks.

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) between July 24 , 202 4 and July 22 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) between January 23 , 202 4 and July 21 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Alto Neuroscience, Inc. (“Alto” or the “Company”) (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about February 2, 2024 (the “IPO” or “Offering”); and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus" or the "Company") (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the first half 2025 on August 29, 2025, before market opening in the United States. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Friday, August 29, 2025 (14:00 Central European Time / 20:00 China Standard Time on the same day).

DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) announced today it plans to break ground in September 2025 on Polaris Forge 2, a $3 billion, 280-megawatt (MW) AI Factory near Harwood, North Dakota. Designed with the ability to scale beyond its initial 280MW, the campus—with initial capacity in 2026 and reaching full capacity in early 2027—further advances Applied Digital's rapid growth and reinforces North Dakota's position as one of the most strategically important destinations for AI infrastructure in the United States.

EDISON, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced the appointment of long-time operations leader, John Mahaz, as Chief Operating Officer (COO).

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) between September 9 , 202 0 and May 1 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company's Chief Financial Officer, effective immediately. Mr. Santos assumes the role from Jessie Yeung, who has served as the interim CFO since January 2025.